Peripheral Neuropathy
213
19
29
102
Key Insights
Highlights
Success Rate
85% trial completion
Published Results
47 trials with published results (22%)
Research Maturity
102 completed trials (48% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 39/100
8.5%
18 terminated out of 213 trials
85.0%
-1.5% vs benchmark
13%
27 trials in Phase 3/4
46%
47 of 102 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 102 completed trials
Clinical Trials (213)
NT-3 Levels and Function in Individuals With CMT
Randomized, Sham-Controlled Investigation of the Leia Sensory Prosthesis in Individuals With Peripheral Neuropathy
WIREDUP: Wearable Insoles for Recurrent Diabetic Ulcer Prevention
Wearable Insoles for Recurrent Diabetic Ulcer Prevention
A Prospective Natural History and Outcome Measure Discovery Study of Charcot-Marie-Tooth Disease, Type 4J
Innovative Treatment of Chemotherapy-Induced Painful Peripheral Neuropathy in Adolescents and Young Adults With Cancer: A Two Arm Pilot Study
Electroacupuncture for Preventing Chemotherapy-Induced Peripheral Neuropathy in Patients With Early-stage Cancer
Sacituzumab Tirumotecan vs MMAE-ADCs in Advanced Urothelial Carcinoma (FUSCC-SPARE-UC-01)
Electroacupuncture for Preventing Chemotherapy-Induced Peripheral Neuropathy in Patients With Advanced Cancer
Prospective Case Series Evaluating 6-Month and 12-Month Outcomes After Cryoneurolysis for Chronic Pain
Teleconsultations Hypnosis Sessions for Patients With Peripheral Chronic Neuropathic Pain
Shortwave Diathermy In-home Treatment for Indianapolis VA-only Patients Diagnosed With Peripheral Artery Disease and Peripheral Neuropathy
Desloratadine to Prevent Taxane-induced Peripheral Neuropathy in Patients With Breast Cancer
Prevention of Oxaliplatin-induced Nerve Damage in the Body's Extremities
Effect of Hands and Feet Exercises on Taxane Based Chemotherapy Induced Peripheral Neuropathy in Patients With Solid Tumors
Acupuncture and Exercise for EV-Pembro-Induced Peripheral Neuropathy
Clinical Trial to Assess the Safety of a Novel Scaffold Biomaterial
Investigational Use of Neuromuscular Ultrasound
Nerve Excitability in Cisplatin-Induced Peripheral Neuropathy
Diode Laser as a Biomarker for Neuropathic Pain of Peripheral Origin.